Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

1st Optimal vs Ro

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
1st Optimal logo

1st Optimal

6.7
★★★☆☆3.4/5

Best for: Patients wanting GLP-1 therapy within a lab-driven functional-medicine program

Visit 1st Optimal
VS
Ro logo

Ro

7.7
★★★3.9/5

Best for: broadest GLP-1 formulary including Foundayo on day-one of launch

Visit Ro

1st Optimal and Ro are both GLP-1 Providers competing for the same patients, but they make different trade-offs on price, coverage, and what's included. In our scoring, Ro starts at $149/mo, and Ro edges ahead overall (7.7 vs 6.7 out of 10). Below we break down pricing, what each plan covers, the six-dimension score, pros and cons, and exactly who should pick which.

Pricing

1st Optimal

Pricing not publicly listed.

Ro

Foundayo (lowest dose, cash pay)Brand-name
$149/mo
orforglipron

Additional membership fees apply

Get alerted when GLP-1 prices drop

Join the GLP-1 price-watch list — we re-verify 390+ providers' prices on their own sites and email you when tracked prices move.

What’s included

1st Optimal

Inclusions not disclosed.

Ro

What the monthly price covers

Medication

Billed separately

Provider visits

Included

Shipping

Not disclosed

Lab work

Included

Coaching

Included

Score breakdown

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

1st Optimal

6.7/10

Overall

Ro

7.7/10

Value25%

6.5A
vs
B
6.0

Effectiveness25%

7.0A
vs
B
9.0

User Experience15%

6.5A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
7.8

Accessibility10%

6.5A
vs
B
7.5

Support10%

7.4A
vs
B
8.5

Features & Coverage

Feature1st OptimalRo
Starting Price$149/mo
Features8 features7 features
States AvailableNot disclosedNot disclosed
Compounded
Brand Name✓ Yes
FSA/HSA Accepted
FDA WarningsNoneNone

About 1st Optimal

1st Optimal is a Michigan-based telehealth and functional-medicine platform offering GLP-1 weight loss medications, including semaglutide and tirzepatide, as once-weekly injections or daily oral tablets. Its model pairs prescription GLP-1 therapy with at-home lab testing, blood-work interpretation, unlimited coaching, and personalized protocols framed around long-term weight loss and longevity. Care is delivered virtually by credentialed providers, and treatments ship to the home with no long-term contracts. The site does not publish monthly pricing or a state list.

Read our full 1st Optimal review →

About Ro

Ro is one of the largest direct-to-patient telehealth companies in the US and operates the most comprehensive obesity care formulary in the category — compounded semaglutide, brand-name Wegovy and Zepbound, and as of April 9 2026, Eli Lilly's new oral GLP-1 Foundayo (orforglipron) starting at $149/month for the lowest dose plus membership.

Read our full Ro review →

Pros & Cons

1st Optimal

What we like

  • Offers both semaglutide and tirzepatide with injectable and oral formats
  • Functional-medicine approach with at-home labs and blood-work interpretation
  • Unlimited coaching and ongoing support included
  • No long-term contracts
  • Board-certified doctors and nurse practitioners referenced

Watch-outs

  • No public monthly pricing disclosed
  • No published state availability list
  • Compounded vs branded sourcing not clarified on site
  • Pricing only revealed after quiz or consultation

Ro

What we like

  • One of the broadest GLP-1 menus: compounded semaglutide, brand Wegovy, brand Zepbound, and oral Foundayo (orforglipron)
  • Among the first telehealth platforms to offer oral Foundayo at launch (April 2026)
  • A licensed provider helps you pick the best GLP-1 based on cost, insurance, and your health goals
  • Nationwide delivery, including 99% of primary-care deserts
  • Both cash-pay and insurance-eligible options on one platform

Watch-outs

  • Foundayo requires a recurring membership on top of the $149/mo drug price, so total cost runs higher
  • Foundayo pricing above the lowest dose isn't shown until intake
  • State availability and pharmacy partners aren't listed publicly — confirmed at signup
  • Membership and medication are billed separately, which can make the true monthly cost confusing

Our Verdict

Winner: Ro

Ro edges out 1st Optimal with a higher overall score of 7.7/10 and is particularly strong for broadest GLP-1 formulary including Foundayo on day-one of launch. 1st Optimal remains a solid alternative, especially if you're looking for Patients wanting GLP-1 therapy within a lab-driven functional-medicine program.

Choose 1st Optimal if…

You want Patients wanting GLP-1 therapy within a lab-driven functional-medicine program.

Choose Ro if…

You want broadest GLP-1 formulary including Foundayo on day-one of launch and a starting price around $149/mo.

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.6

RNK Health

Compounded GLP-1 alongside NAD+, peptide and longevity add-ons

6.2

Wellorithm

Compounded GLP-1 access with oral tablet options across 49 states

7.6

SkinnyRx

Mainstream telehealth GLP-1 access

1st Optimal vs Ro: FAQ

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Continue exploring 1st Optimal and Ro head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.